The Pharmaceutical Industry Labor-Management Association (PILMA) supports policies that strengthen America’s national security, protect public health, and promote innovation and high-quality job growth in the pharmaceutical industry. As such, any use of Section 232 investigations into pharmaceutical products must be carefully tailored to focus strictly on legitimate national security concerns and patients’ health. Section 232 […]
Protecting Patents, Preserving Jobs: PILMA Marks World IP Day
April 26, 2025 The Pharmaceutical Industry Labor-Management Association (PILMA) is proud to join stakeholders from across the biopharmaceutical and labor communities in recognizing World Intellectual Property Day. Today is an opportunity to reflect on the pivotal role of intellectual property (IP) rights in not only powering innovation and the development of new cures but also […]
PILMA Urges Congress to Address IRA’s “Pill Penalty” Following Executive Action
FOR IMMEDIATE RELEASEApril 17, 2025 PILMA Urges Congress to Address IRA’s “Pill Penalty” Following Executive Action Bipartisan EPIC Act offers solution to protect patient access, pharmaceutical innovation, and skilled union construction jobs The Pharmaceutical Industry Labor-Management Association (PILMA) welcomes renewed attention to the harmful impacts of the Inflation Reduction Act’s so-called “pill penalty,” highlighted in […]
The Feds must stop going easy on foreign patent thieves who hurt Pennsylvania | Opinion
Read the article here In the past few months, researchers at the University of Pittsburgh have received more than a dozen patents, including for an experimental probiotic weight-loss therapy, a more durable and flexible solar cell and a new method of detecting and treating pancreatic cancer. But Pitt doesn’t have the ability — or the […]
PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act
February 25, 2025 PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act Bipartisan legislation would correct the “pill penalty” to safeguard union jobs and ensure continued innovation in small-molecule therapies The Pharmaceutical Industry Labor-Management Association (PILMA) applauds the introduction of the Ensuring Pathways to Innovative Cures (EPIC) Act (H.R. 1492), a bipartisan […]
President McManus Letter on PBMs to Congress
November 21, 2024 Dear Speaker Johnson, Leader Jeffries, Leader Schumer, and Leader McConnell, As Congress returns to Washington for the remaining weeks of the legislative session, lawmakers have a critical opportunity to deliver meaningful reforms that will provide relief to millions of hardworking families struggling with high prescription drug costs. As a labor union representing […]